Dermapharm Holding SE (VIE:DMP)

Market Cap	1.89B -13.3%
Revenue (ttm)	1.17B +0.0%
Net Income	116.03M +28.1%
EPS	2.15 +28.3%
Shares Out	n/a
PE Ratio	16.29
Forward PE	14.59
Dividend	0.90 (2.57%)
Ex-Dividend Date	Jun 27, 2025

Volume	n/a
Average Volume	29
Open	35.50
Previous Close	35.35
Day's Range	35.50 - 35.50
52-Week Range	32.05 - 42.45
Beta	n/a
RSI	37.76
Earnings Date	Mar 17, 2026

About Dermapharm Holding SE

Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, France, Spain, Austria, Switzerland, and internationally. The company operates through three segments: Branded Pharmaceuticals, Other Healthcare Products, and Parallel Import Business. It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals. The company also provides vitamins, minerals, food supplements, as well as product...

• Industry: Pharmaceutical Preparations
• Founded: 1991
• Employees: 3,551
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: DMP

Financial Performance

In 2024, Dermapharm Holding SE's revenue was 1.20 billion, an increase of 3.89% compared to the previous year's 1.15 billion. Earnings were 113.79 million, an increase of 82.44%.